Ecnoglutide (10mg Research Vial)
Analytical Standards & Laboratory Handling
Verified laboratory protocols, reconstitution parameters, and handling guidelines.
Pharmacological Profile & Mechanism of Action
What it is: Ecnoglutide (XW003) is a cAMP-biased GLP-1 receptor agonist with an optimized hydrophobic fatty acid diacid moiety that minimizes beta-arrestin recruitment, reducing receptor desensitization and internalization.
How it works: Selective cAMP signaling delivers potent insulinotropic and satiety actions with reduced receptor down-regulation, extending pharmacodynamic duration and improving tolerability.
Why researchers study it: Under active Phase 3 clinical evaluation for robust glycemic control and weight management in obesity.
Compound & Molecular Specifications
Certificate of Analysis StandardsFrequently Stacked with Glutathione (Reduced GSH)
Clinically verified combinations activating complementary physiological pathways without receptor competition.
NAD+ (Nicotinamide Adenine Dinucleotide)
NAD+ replenishes the mitochondrial electron transport chain, generating minor reactive oxygen species (ROS) during oxidative phosphorylation. Glutathione acts as the master intracellular ROS scavenger, converting hydrogen peroxide to water and preserving mitochondrial membrane potential.
